Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from AstraZeneca

Large COVID-19 vaccine study finds risks

Any pharmaceutical has risk of side effects, but a COVID infection is far more dangerous than the vaccines

Salon

Two very rare Covid vaccine side-effects detected in global study of 99 million

Results confirm how uncommon known complications are as researchers confirm benefits from vaccines still ‘vastly outweigh the risks’

The Guardian - AU

Afternoon Update: Woolworths shares plunge; NZ MP dies after charity run; and AstraZeneca boss’s $33m paycheque

Supermarket giant’s CEO resigns unexpectedly amid increasing political pressure over record profits during cost-of-living crisis

The Guardian - AU

From analysis to the latest developments in health,
read the most diverse news in one place.

AstraZeneca boss’s £17m pay package under fire

Corporate governance thinktank questions whether Pascal Soriot’s remuneration – 1,000 times the minimum wage – is justifiable

The Guardian - UK

COVID Vaccines Linked To Slight Increase In Heart And Brain Issues: Large-Scale Study

The researchers cautioned that the study found only associations with adverse health effects and it does not prove that these issues are caused by the vaccines.

Medical Daily

Weight-loss drugs need to become cheaper, says AstraZeneca boss

Loss of muscle mass also flagged, as UK drugmaker works with China’s Eccogene on obesity and type 2 diabetes pill

The Guardian - UK

AstraZeneca Nose Dives On 'Thoroughly Underwhelming' Fourth-Quarter Results

AstraZeneca's quarterly results were "thoroughly underwhelming," an analyst said Thursday as he downgraded AZN stock to a sell rating.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

FTSE 100 Live 8 February: Index closes down 0.4%, S&P still near 5000 with $44bn added to Arm value

London’s long-awaited run of dealmaking action continued today when Tesco unveiled the sale of its banking operations to Barclays.

Evening Standard

Felix Munkonge obituary

Other lives: Specialist in cell biology who helped with the development of a Covid-19 vaccine and treatments for cystic fibrosis

The Guardian - UK

AstraZeneca buys Chinese cancer therapy firm Gracell for $1.2bn

Gracell Biotechnologies acquisition marks China’s growing importance to the Anglo-Swedish drugmaker

The Guardian - UK

AstraZeneca buys US vaccine company in $1.1bn deal

Britain’s biggest drugmaker acquires Seattle-based firm Icosavax, expanding vaccine and immune therapy business

The Guardian - UK

Rare clotting effect of early COVID shots finally explained — what could that mean for future vaccines?

Scientists have offered a new explanation for why COVID-19 vaccines that contained adenoviruses carried a rare-but-serious risk of blood clotting.

LiveScience

AstraZeneca Partners With AI Company to Find Cure For Cancer

Absci, a drug and target discovery company, has been harnessing the power of deep learning AI to develop new and existing disease treatments.

International Business Times UK

COVID-19 Booster Shot: Study Says Half Dose Of Pfizer Vaccine Produces Strong Immune Response

The team discovered that people who previously received AstraZeneca or Sinopharm COVID-19 vaccines had a "non-inferior" immune response when given a half dose of a Pfizer COVID-19 booster vaccine, comparable to those who received a full dose.

Medical Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Will Weight Loss Drugs be the Next Big Thing?

Several pharmaceutical companies are racing to develop obesity drugs and tap into a surge in consumer demand for the extremely profitable drugs. Sales of Eli Lilly’s (LLY ) diabetes drug Mounjaro, just approved by the U.S. Food and Drug Administration (FDA) for obesity in the U.S., hit $1.41 billion in...

Fortune

The corporate world is falling short in the fight against climate change

Only 20% of the top 1,000 companies have targets to reduce their emissions, a sign not enough leaders are taking climate change seriously.

The Conversation

AstraZeneca sued over jab: could it be down to a misunderstanding of how risk is calculated?

A multi-million-pound landmark “vaccine damage” case is set to take place in London’s High Court. The test case is being pursued by Jamie Scott who suffered a severe brain injury in April 2021 after receiving the Oxford-AstraZeneca vaccine.

Investors Business Daily

AstraZeneca Is Making A $2 Billion Bet To Rival Lilly, Novo In Obesity Drugs

AZN stock popped after AstraZeneca said it would spend up to $2.01 billion to license an experimental weight-loss drug from Eccogene.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

AstraZeneca makes big push into weight-loss market with obesity pill deal

UK drugmaker signs agreement with China’s Eccogene to work on an obesity and type 2 diabetes pill

Evening Standard

FTSE 100 Live: London blue-chips climb, AstraZeneca results, Flutter and S4 Capital shares tumble

Shares in FTSE 100 heavyweight Diageo have tumbled after it cut guidance due to lower-than-expected demand in Latin America and the Caribbean.

The Conversation

Why some people got blood clots after the AstraZeneca vaccine – new clues

AstraZeneca in partnership with the University of Oxford developed one of the first vaccines against COVID. The vaccine, which used an adenovirus to smuggle instructions into human cells to make antibodies against the novel coronavirus, saved countless lives. But a problem soon emerged. A tiny proportion – about one in…

The Conversation

We could see thunderstorm asthma in south-eastern Australia this season – here's how to prepare

Victorians have been warned to prepare for the possibility of thunderstorm asthma again this season.

The Independent UK

A new RSV shot for infants is in short supply

A new shot for infants against RSV is in short supply, and U.S. health officials are telling doctors they should prioritize giving the drug to babies at the highest risk of severe disease

Investors Business Daily

Why AstraZeneca's Disappointing Lung Cancer Update Also Tripped Gilead Stock

AstraZeneca stock tumbled Wednesday after its experimental drug led to only a month's benefit over chemotherapy in lung cancer patients.

Investors Business Daily

AstraZeneca Surges As It Takes A Shot At Gilead's Second-Biggest Cancer Drug

AstraZeneca and Daiichi Sankyo said Friday their breast cancer treatment outperformed chemo in a Phase 3 study, and AZN stock jumped.

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.